# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-134375
Filing Date
2021-11-04
Accepted
2021-11-04 16:10:35
Documents
4
Period of Report
2021-12-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2130904-4_def14a.htm | DEF 14A | 628268
2 | GRAPHIC | sg_jillmilne-bw.jpg | GRAPHIC | 7184
3 | GRAPHIC | tm2130904d1-px_01cardbw.jpg | GRAPHIC | 775841
4 | GRAPHIC | tm2130904d1-px_02cardbw.jpg | GRAPHIC | 1232962
| Complete submission text file | 0001104659-21-134375.txt |  | 3402554

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 211380024
SIC: 2834 Pharmaceutical Preparations